 |
|
Risk Factors for Cardiovascular Disease in Women—Reply
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In Reply: Mr Vos and Dr Rose express concern that our primary end point included revascularization procedures. When these are eliminated from the analysis, among those persons in the top quintile of apolipoprotein B100, the relative risk compared with the lowest quintile is 1.62 (95% confidence [CI], 1.05-2.52); non–HDL cholesterol, 1.91 (95% CI, 1.22-2.99); ratio of total cholesterol to HDL cholesterol, 2.84 (95% CI, 1.76-4.60); and high-sensitivity C-reactive protein, 3.14 (95% CI, 1.80-5.47). Thus, as reported for our primary end point, non–HDL cholesterol and the ratio of total cholesterol to HDL cholesterol were superior to apolipoprotein B100 for the end point of "hard" cardiovascular events, and high-sensitivity C-reactive protein remained the single strongest predictor of risk. The total number of deaths in our study is insufficient to robustly address mortality as a single end point.
Dr Sniderman suggests that apolipoprotein B100 would have been superior to non–HDL cholesterol if . . . [Full Text of this Article]
Paul M Ridker, MD
PRidker@partners.org
Julie E. Buring, ScD
Brigham and Women's Hospital
Harvard Medical School
Boston, Mass
RELATED ARTICLES
Risk Factors for Cardiovascular Disease in Women
Eddie Vos and Colin P. Rose
JAMA. 2005;294(22):2843.
EXTRACT
| FULL TEXT
Risk Factors for Cardiovascular Disease in Women
Allan D. Sniderman
JAMA. 2005;294(22):2843-2844.
EXTRACT
| FULL TEXT
Non–HDL Cholesterol, Apolipoproteins A-I and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women
Paul M Ridker, Nader Rifai, Nancy R. Cook, Gary Bradwin, and Julie E. Buring
JAMA. 2005;294(3):326-333.
ABSTRACT
| FULL TEXT
|
